OpenURL Connection Search

Select item for more details and to access through your institution.

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer.
Published in:
Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07131-y
By:
- Niemeijer, A. N.;
- Leung, D.;
- Huisman, M. C.;
- Bahce, I.;
- Hoekstra, O. S.;
- van Dongen, G. A. M. S.;
- Boellaard, R.;
- Du, S.;
- Hayes, W.;
- Smith, R.;
- Windhorst, A. D.;
- Hendrikse, N. H.;
- Poot, A.;
- Vugts, D. J.;
- Thunnissen, E.;
- Morin, P.;
- Lipovsek, D.;
- Donnelly, D. J.;
- Bonacorsi, S. J.;
- Velasquez, L. M.
Publication type:
Article
[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 1929, doi. 10.1007/s00259-023-06143-1
By:
- Adams, H.;
- van de Garde, E. M. W.;
- Vugts, D. J.;
- Grutters, J. C.;
- Oyen, Wim. J.G.;
- Keijsers, R. G.
Publication type:
Article
Application of <sup>89</sup>Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 5, p. 1306, doi. 10.1007/s00259-023-06109-3
By:
- Stergiou, N.;
- Wuensche, T. E.;
- Schreurs, M.;
- Mes, I.;
- Verlaan, M.;
- Kooijman, E. J. M.;
- Windhorst, A. D.;
- Helboe, L.;
- Vergo, S.;
- Christensen, S.;
- Asuni, A. A.;
- Jensen, A.;
- Van Dongen, G. A. M. S.;
- Bang-Andersen, B.;
- Vugts, D. J.;
- Beaino, W.
Publication type:
Article
Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer.
Published in:
2020
By:
- van Helden, E. J.;
- Elias, S. G.;
- Gerritse, S. L.;
- van Es, S. C.;
- Boon, E.;
- Huisman, M. C.;
- van Grieken, N. C. T.;
- Dekker, H.;
- van Dongen, G. A. M. S.;
- Vugts, D. J.;
- Boellaard, R.;
- van Herpen, C. M. L.;
- de Vries, E. G. E.;
- Oyen, W. J. G.;
- Brouwers, A. H.;
- Verheul, H. M. W.;
- Hoekstra, O. S.;
- der Houven van Oordt, C. W. Menke-van
Publication type:
Correction Notice
[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 4, p. 849, doi. 10.1007/s00259-019-04555-6
By:
- van Helden, E. J.;
- Elias, S. G.;
- Gerritse, S. L.;
- van Es, S. C.;
- Boon, E.;
- Huisman, M. C.;
- van Grieken, N. C. T.;
- Dekker, H.;
- van Dongen, G. A. M. S.;
- Vugts, D. J.;
- Boellaard, R.;
- van Herpen, C. M. L.;
- de Vries, E. G. E.;
- Oyen, W. J. G.;
- Brouwers, A. H.;
- Verheul, H. M. W.;
- Hoekstra, O. S.;
- Menke-van der Houven van Oordt, C. W.
Publication type:
Article
Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1495, doi. 10.1007/s00259-019-04284-w
By:
- Ankersmit, M.;
- Hoekstra, O. S.;
- van Lingen, A.;
- Bloemena, E.;
- Jacobs, M. A. J. M.;
- Vugts, D. J.;
- Bonjer, H. J.;
- van Dongen, G. A. M. S.;
- Meijerink, W. J. H. J.
Publication type:
Article

Found: 6

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer.

[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial.

Application of <sup>89</sup>Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody.

Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer.

[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer.

Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer.